本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

24.15
+0.01000.04%
成交量:31.63萬
成交額:765.69萬
市值:32.38億
市盈率:-13.50
高:24.81
開:24.20
低:23.86
收:24.14
52周最高:24.81
52周最低:9.60
股本:1.34億
流通股本:8,495.06萬
量比:0.39
換手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-1.7885
每股收益(LYR):-2.0595
淨資產收益率:-72.92%
總資產收益率:-28.96%
市淨率:9.39
市盈率(LYR):-11.73

資料載入中...

2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/17

重要事件披露

Form 8-K - Current report
2025/05/29

重要事件披露

Form 8-K - Current report
2025/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/14

重要事件披露

Form 8-K - Current report
2025/04/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities